COVID-19: Risk groups, mechanistic insights and challenges.
作者信息
Stein Richard Albert
机构信息
Chemical and Biomolecular Engineering, New York University, Tandon School of Engineering, Brooklyn, NY, USA.
Department of Natural Sciences, LaGuardia Community College, Long Island City, NY, USA.
出版信息
Int J Clin Pract. 2020 Aug;74(8):e13512. doi: 10.1111/ijcp.13512. Epub 2020 May 12.
Abstract
摘要
相似文献
1
COVID-19: Risk groups, mechanistic insights and challenges.新型冠状病毒肺炎：风险群体、机制洞察与挑战
Int J Clin Pract. 2020 Aug;74(8):e13512. doi: 10.1111/ijcp.13512. Epub 2020 May 12.
2
COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?新型冠状病毒肺炎：保持社交距离、血管紧张素转换酶2受体、蛋白酶抑制剂及其他？
Int J Clin Pract. 2020 Jul;74(7):e13503. doi: 10.1111/ijcp.13503. Epub 2020 Apr 6.
3
Preventing the clinical manifestations and disease progression of coronavirus disease using clinically proven protease inhibitors.使用经临床验证的蛋白酶抑制剂预防冠状病毒病的临床表现和疾病进展。
Crit Care. 2020 Aug 18;24(1):511. doi: 10.1186/s13054-020-03235-4.
4
Computer modeling of a potential agent against SARS-Cov-2 (COVID-19) protease.针对 SARS-CoV-2（COVID-19）蛋白酶的潜在药物的计算机建模。
Proteins. 2020 Dec;88(12):1557-1558. doi: 10.1002/prot.25980. Epub 2020 Aug 12.
5
[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].[严重急性呼吸综合征冠状病毒2蛋白酶：开发抗2019冠状病毒病药物的理想靶点]
Med Sci (Paris). 2020 Jun-Jul;36(6-7):555-558. doi: 10.1051/medsci/2020106. Epub 2020 Jun 19.
6
3CL inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.3CL抑制剂作为COVID-19的一种潜在治疗选择：现有证据及正在进行的临床试验
Pharmacol Res. 2020 Jun;156:104779. doi: 10.1016/j.phrs.2020.104779. Epub 2020 Apr 2.
7
Challenges and Ethical Considerations for Trainees and Attending Physicians During the COVID-19 Pandemic.新冠疫情期间实习生和主治医生面临的挑战与伦理考量
J Am Coll Surg. 2020 Aug;231(2):301-302. doi: 10.1016/j.jamcollsurg.2020.05.009. Epub 2020 May 30.
8
Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M.设计用于治疗新冠肺炎的改良药物：严重急性呼吸综合征冠状病毒2主要蛋白酶M的晶体结构
Signal Transduct Target Ther. 2020 May 9;5(1):67. doi: 10.1038/s41392-020-0178-y.
9
Value and Challenges: Nucleic Acid Amplification Tests for SARS-CoV-2 in Hospitalized COVID-19 Patients.价值与挑战：住院COVID-19患者中SARS-CoV-2的核酸扩增检测
J Infect. 2020 Aug;81(2):e65-e67. doi: 10.1016/j.jinf.2020.04.036. Epub 2020 Apr 30.
10
Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.2019冠状病毒病（COVID-19）：口腔医学面临的新出现和未来挑战
J Dent Res. 2020 Aug;99(9):1113. doi: 10.1177/0022034520932149. Epub 2020 May 28.
引用本文的文献
1
Correlation between Previous Antibiotic Exposure and COVID-19 Severity. A Population-Based Cohort Study.既往抗生素暴露与新冠病毒病严重程度的相关性。一项基于人群的队列研究。
Antibiotics (Basel). 2021 Nov 8;10(11):1364. doi: 10.3390/antibiotics10111364.
2
Changes in physical activity and basic psychological needs related to mental health among people with physical disability during the COVID-19 pandemic in Norway.挪威 COVID-19 大流行期间身体残疾人群的身体活动变化与心理健康相关的基本心理需求。
Disabil Health J. 2021 Oct;14(4):101126. doi: 10.1016/j.dhjo.2021.101126. Epub 2021 May 30.
3
COVID-19: breaking down a global health crisis.COVID-19：破解一场全球健康危机。
Ann Clin Microbiol Antimicrob. 2021 May 18;20(1):35. doi: 10.1186/s12941-021-00438-7.
4
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.在 COVID-19 大流行期间的ATTR 淀粉样变：来自全球医学圆桌会议的见解。
Orphanet J Rare Dis. 2021 May 6;16(1):204. doi: 10.1186/s13023-021-01834-0.
5
Effect of COVID-19 Lockdown on Dietary Habits and Lifestyle of Food Science Students and Professionals from Spain.新冠疫情封锁对西班牙食品科学专业学生和专业人士饮食习惯和生活方式的影响。
Nutrients. 2021 Apr 28;13(5):1494. doi: 10.3390/nu13051494.
6
Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients.2019冠状病毒病在糖尿病患者肺部的病理生理学
Front Physiol. 2020 Dec 10;11:587013. doi: 10.3389/fphys.2020.587013. eCollection 2020.
7
Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?性激素使人类气道中的 ACE2 表达偏向一方：这是 COVID-19 中性别差异的一个促成因素吗？
Am J Physiol Lung Cell Mol Physiol. 2020 Nov 1;319(5):L843-L847. doi: 10.1152/ajplung.00391.2020. Epub 2020 Sep 30.
8
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.蜂胶及其对 SARS-CoV-2 感染机制和 COVID-19 疾病的潜在作用：标题：蜂胶抗 SARS-CoV-2 感染和 COVID-19。
Biomed Pharmacother. 2020 Nov;131:110622. doi: 10.1016/j.biopha.2020.110622. Epub 2020 Aug 17.
9
[Basic principles of replication and immunology of SARS-CoV-2].[严重急性呼吸综合征冠状病毒2的复制与免疫学基本原理]
Ophthalmologe. 2020 Jul;117(7):609-614. doi: 10.1007/s00347-020-01155-w.
10
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?2019年新型冠状病毒病（COVID-19）疫情：系统性硬化症患者面临哪些风险？
Autoimmun Rev. 2020 Jul;19(7):102558. doi: 10.1016/j.autrev.2020.102558. Epub 2020 May 5.
本文引用的文献
1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病（COVID-19）疫情的流行病学特征 - 中国，2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.儿童感染 SARS-CoV-2 的特征及粪便中持续存在病毒的潜在证据。
Nat Med. 2020 Apr;26(4):502-505. doi: 10.1038/s41591-020-0817-4. Epub 2020 Mar 13.
3
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.血管紧张素转化酶抑制剂改善合并高血压的 COVID-19 患者的临床结局。
Emerg Microbes Infect. 2020 Dec;9(1):757-760. doi: 10.1080/22221751.2020.1746200.
4
Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.COVID-19 是否令肾病学家担忧？原因是什么？程度如何？血管紧张素阻断的新困境。
Nephron. 2020;144(5):213-221. doi: 10.1159/000507305. Epub 2020 Mar 23.
5
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?严重急性呼吸综合征冠状病毒2：2019冠状病毒病患者是否应停用肾素-血管紧张素系统抑制剂？
Eur Heart J. 2020 May 14;41(19):1801-1803. doi: 10.1093/eurheartj/ehaa235.
6
COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?新型冠状病毒肺炎：保持社交距离、血管紧张素转换酶2受体、蛋白酶抑制剂及其他？
Int J Clin Pract. 2020 Jul;74(7):e13503. doi: 10.1111/ijcp.13503. Epub 2020 Apr 6.
7
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.估算 2020 年日本横滨钻石公主号游轮上的 2019 年冠状病毒病（COVID-19）病例的无症状比例。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180.
8
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
9
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
10
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.新加坡 2019 年新型冠状病毒肺炎患者的流行病学特征和临床病程
JAMA. 2020 Apr 21;323(15):1488-1494. doi: 10.1001/jama.2020.3204.
Zotero 插件